Trial Profile
Study of safinamide in patiens with restless legs syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Safinamide (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 30 Jul 2018 New trial record